CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 277 enrolled
Drug / intervention
IV Diclofenac +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00507026
NCT00507026Phase 3Completed

Randomized, Double-Blind, Active-and Placebo-Controlled Study of the Analgesic Efficacy and Safety of Repeated Dosing of DIC075V Versus Parenteral Ketorolac and Placebo in Acute Post-Operative Pain After Elective Orthopedic Surgery

Pfizer·interventional·Posted Jul 25, 2007·Updated Oct 29, 2021

In Brief

A Phase 3 clinical trial evaluating IV Diclofenac, IV ketorolac, and 1 other intervention for Postoperative Pain. Completed, enrolled 277 participants across 8 sites.

Detailed Summary

This study will compare repeated intermittent IV dosing of diclofenac in patient with moderate to severe post-surgical pain from elective orthopedic surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 25, 2007
Enrollment StartJul 25, 2007
Primary CompletionOct 14, 2008
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 18.9 years ago

Interventions

IV Diclofenacdrug

IV Diclofenac q6h

IV ketorolacdrug

IV ketorolac q6h

Placebodrug

Placebo q6h